1. Eldorado
  2. Zentrale und angegliederte Institute
  3. Leibniz-Institut für Arbeitsforschung an der TU Dortmund
  4. Excli - Experimental and Clinical Sciences
  5. 2014 - Volume 13
  6. Review Articles
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFinelli, Carmine-
dc.contributor.authorMartelli, Giuseppe-
dc.contributor.authorRossano, Rocco-
dc.contributor.authorPadula, Maria Carmela-
dc.contributor.authorLa Sala, Nicolina-
dc.contributor.authorSommella, Luigi-
dc.contributor.authorTarantino, Giovanni-
dc.date.accessioned2014-07-25T08:58:01Z-
dc.date.available2014-07-25T08:58:01Z-
dc.date.issued2014-05-26-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/33547-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-824-
dc.description.abstractIn this article, we review on the current concepts about Nesfatin-1 as a new anti-obesity treatment and evaluate the existing issues in the context of this knowledge and the available literature. The intent is to enable clinicians to know Nesfatin-1 as a new anti-obesity treatment and make rational decisions based on this perspective as possible clinical application. Future research should seek to clarify whether Nesfatin-1 would be beneficial in the management of obesity.en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal ; Vol. 13, 2014en
dc.subjectnesfatin-1en
dc.subjectobesityen
dc.subjectdrug treatmenten
dc.subject.ddc610-
dc.titleNesfatin-1en
dc.title.alternativerole as possible new anti-obesity treatmenten
dc.typeText-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
Appears in Collections:Review Articles

Files in This Item:
File Description SizeFormat 
Finelli_26052014_proof.pdfDNB89.73 kBAdobe PDFView/Open


This item is protected by original copyright

View License
Show simple item record


This item is protected by original copyright rightsstatements.org